Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

Photo of Shin, Sejeong

Sejeong Shin, PhD

Research Assistant Professor

Department of Physiology and Biophysics

Contact

Building & Room:

COMRB 5060

Office Phone:

312-355-4436

Related Sites:

About Heading link

Dr. Shin earned her Ph.D. in Structural Biology from the Pohang University of Science and Technology (POSTECH) in South Korea, focusing on protein structure and structure-function relationships using X-ray crystallography. As a postdoctoral fellow at Harvard Medical School, she focused her research on the RAS/ERK, TGF-beta, and PI3K/AKT signaling pathways, particularly studying their roles in epithelial-mesenchymal transition (EMT) during cancer progression. Since joining the University of Illinois College of Medicine in 2016, her research has expanded to include the mTOR, PI3K/AKT, RAS/ERK, and TGF-beta pathways to advance cancer treatment strategies.

Research/Teaching Heading link

Dr. Shin’s research focuses on understanding the mTOR, PI3K/AKT, RAS/ERK, and TGF-beta signaling pathways to uncover therapeutic strategies for cancer. Her work explores the mechanisms of EMT, the mTOR feedback loop, and drug resistance to targeted therapies, with the goal of advancing effective cancer treatments.

Selected Publications

Shin S, Han MJ, Jedrychowski MP, Zhang Z, Shokat KM, Plas DR, Dephoure N, Yoon SO. (2023) mTOR inhibition reprograms cellular proteostasis by regulating eIF3D-mediated selective mRNA translation and promotes cell phenotype switching. Cell Reports, 42, 112868

Shin S, Buel GR, Nagiec MJ, Han MJ, Roux PP, Blenis J, and Yoon SO (2019). ERK2 regulates epithelial to mesenchymal plasticity through DOCK10-dependent Rac1/FoxO1 activation. Proc Natl Acad Sci USA. 116, 2967-2976

Yoon SO*, Shin S*, Karreth FA, Buel GR, Jedrychowski MP, Plas DR, Dedhar S, Gygi SP, Roux PP Dephoure N, Blenis J. (2017) Focal adhesion- and IGF1R-dependent survival and migratory pathways mediate tumor resistance to mTORC1/2 inhibition. Mol Cell, 67, 512-527 *co-first author

Shin S, Buel GR, Wolgamott L, Plas DR, Asara JM, Blenis J, Yoon SO (2015). ERK2 mediates metabolic stress response to regulate cell fate. Mol Cell, 59, 382-398

Shin S, Dimitri CA, Yoon SO, Dowdle W, and Blenis J. (2010) ERK2, but not ERK1, induces epithelial to mesenchymal transformation via DEF motif-dependent signaling events. Mol Cell 38, 114-127